WELLINGTON MANAGEMENT GROUP LLP
Position in OLMA — Olema Pharmaceuticals, Inc.
CIK 902219
Boston, MA
Position in OLMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,585,838
-$3,324,523 QoQ
Shares Held
526,446
-20.8% QoQ
Ownership
0.602%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 182 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0%
Shared 69%
None 31%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. OLMA ranks #84 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in OLMA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,585,838 | 526,446 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,910,361 | 664,679 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,524,275 | 220,971 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,999,185 | 204,207 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $971,368 | 228,021 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,541,030 | 1,473,679 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,893,569 | 1,525,484 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,972,057 | 1,002,685 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,794,879 | 905,257 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,459,138 | 835,613 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,394,763 | 99,413 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,224,144 | 99,121 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $551,823 | 61,110 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $1,123,254 | 275,984 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,209,044 | 988,039 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,898,858 | 2,019,109 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $45,452,061 | 1,649,204 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $45,224,016 | 1,616,298 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $66,864,832 | 2,015,215 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $99,492,663 | 2,069,315 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||